Endovascular treatment appears to be safe and efficacious in patients with large vessel occlusion stroke in patients using oral anticoagulation (OAC). This was suggested by the outcomes of a large-scale retrospective study analysing data from the German Stroke Registry-Endovascular Treatment .
Primary outcomes were successful recanalisation, defined as modified thrombolysis in cerebral infarction (mTICI 2b-3), good outcome at 3 months according to modified Rankin scale (mRS; 0-2 or back to baseline), and rates of intracranial haemorrhage (ICH) until hospital discharge.
The analysis included 2,521 stroke patients, of whom 442 (17.6%) were treated with OACs, 201 (8.0%) with vitamin-K antagonists (VKA), and 241 (9.6%) with non-vitamin-K antagonist oral anticoagulants (NOACs). OAC users were older, had more often a history of atrial fibrillation, and had a higher rate of arterial hypertension (see Table).
The rate of mTICI 2b-3 was similar amo...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Thrombus location and length predictors of early neurological deterioration Next Article
Early edoxaban may be safe after cardioembolic stroke »
Table of Contents: EAN 2020
Headache and Pain
Neuromyelitis Optica Spectrum Disorder
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.